Glutamate receptors participate in the nicotine-induced changes of met-enkephalin in striatum

Brain Research

Volumn 878, Issue 1-2, 2000, Pages 72-78

  Isola, Raffaella ^a   Duchemin, Anne Marie ^a   Tejwani, Gopi A ^a   Neff, Norton H ^a   Hadjiconstantinou, Maria ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Dopamine D1 and D2 receptors; GABA(A) and GABA(B) receptors; Glutamate NMDA and AMPA receptors; Met enkephalin; Nicotine; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BICUCULLINE; DOPAMINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; METENKEPHALIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NICOTINE; QUISQUALIC ACID RECEPTOR; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANIMAL; CORPUS STRIATUM; ENKEPHALIN, METHIONINE; MALE; MICE; NICOTINE; RECEPTORS, AMPA; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; RECEPTORS, GABA-B; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034730449     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02690-1     Document Type: Article

References (54)

1. Abbod M.E., Eberwine J.H., Erdelyi E., Evans C.J. Regulation of both preproenkephalin mRNA and its derived opioids by haloperidol - a method for measurement of peptides and mRNA in the same tissue extract. Mol. Brain Res. 8:1990;243-248.
2. Angulo J.A., Mc Ewen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19:1994;1-28.
3. Beckstead R.M. N-Methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum. Synapse. 21:1995;342-347.
4. Benowitz N.L. Cigarette smoking and nicotine addiction. Med. Clin. North Am. 76:1992;415-436.
5. Bourgoin S., Artaud F., Cesselin F., Glowinski J., Hamon M. Local and remote effects of intra-caudate administration of GABA-related drugs on met-enkephalin release in the basal ganglia. Brain Res. 361:1985;361-372.
6. Bernard V., Somogyi P., Bolam J.P. Cellular, subcellular, and subunit distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J. Neurosci. 17:1997;819-833.
7. Cesselin F., Soubrié P., Bourgoin S., Artaud F., Reisine T.D., Michelot R., Glowinski J., Hamon M. In vivo release of met-enkephalin in the cat brain. Neuroscience. 6:1981;301-313.
8. Chen Q., Veenman C.L., Reiner A. Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated neurotoxicity. Neuroscience. 73:1996;715-731.
9. Chen Q., Reiner A. Cellular distribution of the NMDA receptor NR2A/2B subunits in the rat striatum. Brain Res. 743:1996;346-352.
10. 3H]-α-bungarotoxin. J. Neurosci. 5:1985;1307-1315.
11. Corrigall W.A. Understanding the brain mechanisms in nicotine reinforcement. Br. J. Addict. 86:1991;507-510.
12. Dani J.A., Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron. 16:1996;905-908.
13. De Ceballos M.L., Jenner P., Marsden C.D. Acute and repeated administration of sulpiride alters met- and leu-enkephalin content of rat brain. Neurosci. Lett. 68:1986;322-326.
14. Deutch A.Y., Holliday J., Roth R.H., Chun L.L.Y., Hawrot E. Immunohistological localization of a neuronal nicotinic acetylcholine receptor in mammalian brain. Proc. Natl. Acad. Sci. USA. 84:1987;8697-8701.
15. Dhatt R.K., Krishnamurthy G.P., Wemlinger T.A., Tejwani G.A., Neff N.H., Hadjiconstantinou M. Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine. J. Neurochem. 64:1995;1878-1883.
16. Goldman D., Deneris E., Luyten W., Kochlar A., Patrick J., Heinemann S. Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cell. 48:1987;965-973.
17. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-253.
18. 3H]cytisine. Neuroscience. 62:1994;929-944.
19. Helton D.R., Tizzano J.P., Monn J.A., Schoepp D.D., Kallman M.J. LY354740 a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats. Neuropharmacology. 36:1997;1511-1516.
20. Hexum T.D., Russet L.R. Plasma enkephalin-like peptide response to chronic nicotine infusion in guinea pig. Brain Res. 406:1987;370-372.
21. Houdi A.A., Pierzchala K., Marson L., Palkovits M., Van Loon G.R. Nicotine-induced alteration in Tyr-Gly-Gly and met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides. 12:1991;161-166.
22. Houdi A.A., Dasgupta R., Kindy M.S. Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res. 799:1998;257-263.
23. Jensen R.A., Gilbert D.G., Meliska C.J., Landrum T.A. Characterization of a dose-response curve for nicotine-induced conditioned taste aversion in rats: relationship to elevation of plasma beta-endorphin concentration. Behav. Neural. Biol. 53:1990;428-440.
24. Kerkerian L., Nieoullon A. Effects of acetylcholine on sodium-dependent high-affinity glutamate transport in rat striatal homogenates. J. Neurochem. 40:1983;1287-1292.
25. Landwehrmeyer G.B., Standaert D.G., Testa C.M., Penney J.B., Young A.B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15:1995;5297-5307.
26. Lindstrom J. Neuronal nicotinic acetylcholine receptors. Narahashi T. Ion Channels. Vol. 4:1996;377-450 Plennum Press, New York.
27. Llorens-Cortes C., Van Amsterdam J.G.C., Giros B., Quach T.T., Schwartz J.C. Enkephalin biosynthesis and release in mouse striatum are inhibited by GABA receptor stimulation: compared changes in preproenkephalin mRNA and Tyr-GLy-Gly levels. Mol. Brain Res. 8:1990;227-233.
28. Lu Y., Grady S., Marks M.J., Picciotto M., Changeux J.-P., Collins A.C. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 287:1998;648-657.
29. Marty M.A., Ervin V.G., Cornell K., Zgomblick J.M. Effects of nicotine on alpha-endorphin, beta-MSH and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro. Pharmacol. Biochem. Behav. 22:1985;317-325.
30. Parent A., Hazrati L.-N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglio-thalamo-cortical loop. Brain Res. Rev. 20:1995;91-127.
31. Pierzchala K., Houdi A.A., Van Loon G.R. Nicotine-induced alterations of brain regional concetrations of native and cryptic met- and leu-enkephalin. Peptides. 8:1987;1035-1043.
32. Pomerleau O.F., Fertig J.B., Seyer L.E., Jaffe J. Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology. 8:1983;61-67.
33. Reid M.S., Fox L., Ho L.B., Berger S.P. Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization. Synapse. 53:2000;129-136.
34. Ruzicka B.B., Jhamandas K. Elevation of met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins. Brain Res. 536:1990;227-239.
35. Ruzicka B.B., Jhamandas K. Met-enkephalin release from slices of the rat striatum and globus pallidus: stimulation by excitatory amino acids. J. Pharmacol. Exp. Ther. 257:1991;1025-1033.
36. Schilström B., Nomikos G.G., Nissel M., Hertel P., Svensson T.H. N-methyl-D-aspartate receptor stimulation antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience. 82:1993;781-789.
37. Shoaib M., Stolerman I.P. MK801 attenuates behavioural adaptation to chronic nicotine administration in rats. Br. J. Pharmacol. 105:1992;514-515.
38. Shoaib M., Benwel M.E.M., Akbar M.T., Stolerman I.P., Balfour D.J.K. Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. Br. J. Pharmacol. 111:1994;1073-1080.
39. Shoaib M., Schindler C.W., Goldberg S.T., Pauly J.R. Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist. Neuropsychopharmacology. 134:1997;121-130.
40. 5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence. Mol. Brain Res. 8:1990;143-158.
41. 5-enkephalin biosynthesis in neurons of the rat striatum. J. Pharmacol. Exp. Ther. 262:1992;823-833.
42. Somogyi P., Priestly J.V., Cuello A.C., Smith A.D., Takagi H. Synaptic connections of enkephalin-immunoreactive nerve terminals in the neostriatum: a correlated light and electron microscopic study. J. Neurocytol. 11:1982;779-807.
43. Stolerman I.P., Shoaib M. The neurobiology of tobacco addiction. Trends Pharmacol. Sci. 12:1991;467-473.
44. Stolerman I.P. Drugs of abuse: behavioural principles, methods and terms. Trends Pharmacol. Sci. 13:1992;170-176.
45. Sziráki I., Sershen H., Benuck M., Hashim A., Lajtha A. Receptor systems participating in nicotine-specific effects. Neurochem. Int. 33:1998;445-457.
46. Tallasken-Greene S.J., Albin R.L. Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons. Neuroscience. 61:1994;509-519.
47. 5]-enkephalin and neurotensin content in the rat. Biochem. Pharmacol. 41:1991;1385-1391.
48. Tejwani G.A., Vaswani K.K., Barbacci J.C. Effect of oral contraceptives on the rat brain and pituitary opioid peptides. Peptides. 6:1985;555-561.
49. Toth E., Vizi E.S., Lajtha A. Effect of nicotine on levels of extracellular amino acids in regions of the rat brain. Neuropharmacology. 32:1993;827-832.
50. Uhl G.R., Navia B., Douglas J. Differential expression of preproenkephalin and preprodynorphin mRNAs in striatal neurons: high levels of preproenkephalin expression depend on cerebral cortical afferents. J. Neurosci. 8:1988;4755-4764.
51. Vizi E.S., Lendvai B. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Rev. 30:1999;219-235.
52. Wada E., Wada K., Boulter J., Deneris E., Heineman S., Patrick J., Swanson L.W. Distribution of alpha2, alpha3, alpha4 and beta2 neuronal nicotine receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284:1989;314-335.
53. Wang J.Q., McGinty J.F. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum. Mol. Brain Res. 54:1998;262-269.
54. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.